Caribou Biosciences Inc

{ "date": [ "202612", "202712", "202812", "202912", "203012" ], "revenue_estimate": [ 10.78, 12.67, 35.12, 93.7, 207.1 ], "ebit_estimate": [ -132.09, -166.91, -193.47, -198.7, -312.93 ], "ebitda_estimate": [ -153.05, -182.48, -182.62, null, null ], "net_income_estimate": [ -125.22, -156.96, -182.1, -246.9, -273.9 ], "per_share_eps_estimate": [ -1.19, -1.42, -1.77, -2.4, -2.69 ], "eps_nri_estimate": [ -1.19, -1.41, -1.64, -2.4, -2.69 ], "dividend_estimate": [ null, null, null, null, null ], "book_value_per_share_estimate": [ null, null, null, null, null ], "pretax_income_estimate": [ -127.4, -163.8, -194.37, -276.47, -314.93 ], "operating_cash_flow_per_share_estimate": [ -0.68, -1.29, -1.87, -3.49, null ], "roa_estimate": [ -69.5, -97.1, -54, -107.3, null ], "roe_estimate": [ -110.09, 115.04, -0.76, 57.3, null ], "gross_margin_estimate": [ 100, 100, 100, null, 80 ], "operating_cash_flow_estimate": [ -64.71, -123.66, -179.26, -334.56, null ], "pettm_estimate": [ 0, 0, 0, 0, 0 ], "long_term_growth_rate_mean": 0, "long_term_revenue_growth_rate_mean": "43.36", "future_per_share_eps_estimate_growth": null, "future_eps_nri_estimate_growth": null, "future_revenue_estimate_growth": 43.36, "future_ebit_estimate_growth": -10.86, "future_ebitda_estimate_growth": -9.13, "future_dividend_estimate_growth": null, "future_net_income_estimate_growth": -8.82, "future_pretax_income_estimate_growth": -11.13, "future_book_value_per_share_estimate_growth": null, "future_roa_estimate_growth": null, "future_roe_estimate_growth": null, "future_gross_margin_estimate_growth": null, "future_operating_cash_flow_per_share_estimate_growth": null }

{ "date": [ "202606", "202609", "202612" ], "revenue_estimate": [ 2.28, 2.2, 18.84 ], "ebit_estimate": [ -33.23, -40.17, -32.46 ], "ebitda_estimate": [ -32.49, -40.98, -55.65 ], "net_income_estimate": [ -31.07, -37.45, -42.47 ], "per_share_eps_estimate": [ -0.32, -0.36, -0.24 ], "eps_nri_estimate": [ -0.32, -0.36, -0.29 ], "dividend_estimate": [ null, null, null ], "book_value_per_share_estimate": [ null, null, null ], "pretax_income_estimate": [ -31.22, -37.93, -27.24 ], "operating_cash_flow_per_share_estimate": [ 0.3, -0.67, -0.53 ], "roa_estimate": [ 21.3, null, -19.8 ], "roe_estimate": [ -34.7, -54.81, -173.56 ], "gross_margin_estimate": [ null, null, null ], "operating_cash_flow_estimate": [ 28.76, -64.23, -50.81 ], "pettm_estimate": [ null, null, null ], "long_term_growth_rate_mean": 0, "long_term_revenue_growth_rate_mean": "43.36", "future_per_share_eps_estimate_growth": null, "future_eps_nri_estimate_growth": null, "future_revenue_estimate_growth": 43.36, "future_ebit_estimate_growth": -10.86, "future_ebitda_estimate_growth": -9.13, "future_dividend_estimate_growth": null, "future_net_income_estimate_growth": -8.82, "future_pretax_income_estimate_growth": -11.13, "future_book_value_per_share_estimate_growth": null, "future_roa_estimate_growth": null, "future_roe_estimate_growth": null, "future_gross_margin_estimate_growth": null, "future_operating_cash_flow_per_share_estimate_growth": null }